Aliases & Classifications for Arthritis

Aliases & Descriptions for Arthritis:

Name: Arthritis 38 12 29 52 41 3 42 14 69
Inflammatory Joint Disease 52 69
Inflammatory Disorder of Joint 12

Classifications:



External Ids:

Disease Ontology 12 DOID:848
MeSH 42 D001168
NCIt 47 C2883
UMLS 69 C0003864

Summaries for Arthritis

MedlinePlus : 41 if you feel pain and stiffness in your body or have trouble moving around, you might have arthritis. most kinds of arthritis cause pain and swelling in your joints. joints are places where two bones meet, such as your elbow or knee. over time, a swollen joint can become severely damaged. some kinds of arthritis can also cause problems in your organs, such as your eyes or skin. types of arthritis include osteoarthritis is the most common type of arthritis. it's often related to aging or to an injury. autoimmune arthritis happens when your body's immune system attacks healthy cells in your body by mistake. rheumatoid arthritis is the most common form of this kind of arthritis. juvenile arthritis is a type of arthritis that happens in children. infectious arthritis is an infection that has spread from another part of the body to the joint. psoriatic arthritis affects people with psoriasis. gout is a painful type of arthritis that happens when too much uric acid builds up in the body. it often starts in the big toe. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary : Arthritis, also known as inflammatory joint disease, is related to rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies and rheumatoid arthritis, and has symptoms including arthralgia, back pain and metatarsalgia. An important gene associated with Arthritis is MMP3 (Matrix Metallopeptidase 3), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Rayos and Adalimumab have been mentioned in the context of this disorder. Affiliated tissues include t cells, bone and monocytes, and related phenotypes are Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression and homeostasis/metabolism

Disease Ontology : 12 A bone inflammation disease that involves a response to irritation or injury, characterized by joint pain, swelling, stiffness located in joint and/or redness located in skin over the joint.

Wikipedia : 71 Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include... more...

Related Diseases for Arthritis

Diseases in the Arthritis family:

Transient Arthritis

Diseases related to Arthritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1200)
id Related Disease Score Top Affiliating Genes
1 rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies 33.3 IL1B IL6 TNF
2 rheumatoid arthritis 33.2 ADAM17 CCL2 CXCL8 IL17A IL1A IL1B
3 camptodactyly-arthropathy-coxa vara-pericarditis syndrome 31.9 CCL2 CXCL8 IL1B IL6 MMP9 TNF
4 osteonecrosis 31.6 CXCL8 IL1B IL6 MMP1 MMP13 MMP3
5 skin conditions 31.3 CCL2 CXCL8 IL1A IL1B IL1RN TNF
6 tuberculosis 30.6 CCL2 IL17A IL1B IL6 TNF
7 pyoderma gangrenosum 30.4 CXCL8 IL1B IL6 TNF
8 neuropathy 30.3 CXCL8 IL1B IL6 TNF
9 meningitis 30.2 CXCL8 IL1A IL6 TNF
10 celiac disease 30.0 IL17A IL1RN MMP3 TNF TNFSF11
11 collagenous colitis 30.0 CXCL8 IL17A IL1B IL6 PTGS2 TNF
12 hidradenitis 30.0 CXCL8 IL1B PTGS2
13 cellulitis 29.8 MMP3 MMP9 SAA1
14 subcorneal pustular dermatosis 29.8 CCL2 CXCL8 IL17A IL1B IL6 MMP9
15 dermatitis herpetiformis 29.8 IL17A MMP3 TNF
16 measles 29.8 IL1B IL6 TNF
17 myocardial infarction 29.7 CCL2 IL1B IL6 MMP3 MMP9 PTGS2
18 complex regional pain syndrome 29.6 CCL2 IL17A IL1B MMP9 TNF
19 central nervous system lymphoma 29.6 CCL2 IL1B IL6 TNF
20 pyelonephritis 29.6 CXCL8 IL1B TNF
21 allergic bronchopulmonary aspergillosis 29.6 CCL2 CXCL8 IL6
22 paragonimiasis 29.5 CXCL8 IL17A IL6
23 swine influenza 29.4 IL1A IL6 TNF
24 glucose intolerance 29.4 CCL2 CXCL8 TNF
25 proctitis 29.4 ADAM17 IL6 MMP9 PTGS2
26 stomatitis 29.4 CXCL8 IL1RN IL6
27 histiocytosis 29.3 CXCL8 IL17A IL1A IL1B IL1RN IL6
28 choroiditis 29.3 CCL2 CXCL8 IL1B IL6 TNF
29 acute kidney failure 29.3 CXCL8 IL1A IL1RN TNF
30 breast abscess 29.3 IL6 MMP1 MMP13 MMP9
31 cowpox 29.3 CXCL8 IL1B IL1RN
32 atrophic gastritis 29.3 CCL2 CXCL8 IL17A TNF
33 keratoconus 29.2 IL17A IL1B IL1RN IL6 MMP3 TNF
34 rheumatoid arthritis, systemic juvenile 12.4
35 septic arthritis 12.4
36 psoriatic arthritis 12.3
37 reactive arthritis 12.3
38 psoriatic juvenile idiopathic arthritis 12.2
39 enthesitis-related juvenile idiopathic arthritis 12.2
40 oligoarticular juvenile idiopathic arthritis 12.0
41 pyogenic sterile arthritis, pyoderma gangrenosum, and acne 12.0
42 systemic onset juvenile idiopathic arthritis 11.9
43 pyogenic arthritis, pyoderma gangrenosum and acne 11.9
44 rheumatoid factor-negative juvenile idiopathic arthritis 11.9
45 transient arthritis 11.9
46 polyarticular onset juvenile idiopathic arthritis 11.9
47 rheumatoid factor-positive polyarticular juvenile idiopathic arthritis 11.8
48 oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies 11.8
49 oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies 11.8
50 unspecified juvenile idiopathic arthritis 11.8

Graphical network of the top 20 diseases related to Arthritis:



Diseases related to Arthritis

Symptoms & Phenotypes for Arthritis

UMLS symptoms related to Arthritis:


arthralgia, back pain, metatarsalgia, muscle cramp, sciatica, joint swelling, joint stiffness

GenomeRNAi Phenotypes related to Arthritis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression GR00224-A-2 8.8 IL1A MMP13 MMP9

MGI Mouse Phenotypes related to Arthritis:

44 (show all 11)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.33 MMP13 MMP3 MMP9 PTGES PTGS2 PTPN22
2 immune system MP:0005387 10.3 ADAM17 CCL2 IL17A IL1A IL1B IL1RN
3 hematopoietic system MP:0005397 10.28 MMP3 MMP9 PTGES PTGS2 ADAM17 IL17A
4 cardiovascular system MP:0005385 10.24 ADAM17 IL1A IL1B IL1RN IL6 MMP13
5 endocrine/exocrine gland MP:0005379 10.11 ADAM17 IL17A IL6 PTGS2 PTPN22 TNF
6 integument MP:0010771 10.1 ADAM17 IL1A IL1B IL1RN IL6 MMP13
7 digestive/alimentary MP:0005381 10.08 TNFRSF11A ADAM17 IL17A IL6 MMP9 PTGS2
8 neoplasm MP:0002006 9.91 IL1A IL1B IL6 MMP1 MMP9 PTGS2
9 reproductive system MP:0005389 9.81 IL6 MMP9 PTGS2 TNF TNFAIP6 TNFRSF11A
10 respiratory system MP:0005388 9.65 TNFRSF11A TNFSF11 ADAM17 IL17A IL6 MMP9
11 skeleton MP:0005390 9.4 ADAM17 IL17A IL1B IL1RN IL6 MMP13

Drugs & Therapeutics for Arthritis

FDA approved drugs:

id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Rayos 17 PREDNISONE Horizon Pharma Approved July of 2012

Drugs for Arthritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 883)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
2
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
3
Abatacept Approved Phase 4,Phase 3,Phase 2,Phase 1 332348-12-6 10237
4
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 185243-69-0
5
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
6
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1 174722-31-7 10201696
7
Hydroxychloroquine Approved Phase 4,Phase 3,Phase 2,Phase 1 118-42-3 3652
8
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 83-43-2 6741
9
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 16590-41-3 5360515
10
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-24-8 5755
11
Sulfasalazine Approved Phase 4,Phase 3,Phase 2 599-79-1 5353980 5359476
12
Leflunomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75706-12-6 3899
13
Diclofenac Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 15307-86-5 3033
14
Etoricoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 202409-33-4 123619
15
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1 428863-50-7
16
Cimetidine Approved Phase 4,Phase 3,Phase 2 51481-61-9 2756
17
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-02-2 5743
18
Spironolactone Approved Phase 4,Phase 2 1952-01-7, 52-01-7 5833
19
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 169590-42-5 2662
20
Naproxen Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22204-53-1 1302 156391
21
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 9004-61-9 53477741 24759
22
Dimethyl fumarate Approved, Investigational Phase 4,Phase 2,Phase 1 624-49-7 637568 5271565
23
Zinc Approved Phase 4,Phase 2 7440-66-6 32051 23994
24
Polidocanol Approved Phase 4 9002-92-0
25
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
26
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
27
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Phase 1 103-90-2 1983
28
Methyclothiazide Approved Phase 4 135-07-9 4121
29
Azathioprine Approved Phase 4,Phase 3,Phase 2 446-86-6 2265
30
Rivaroxaban Approved Phase 4,Phase 3 366789-02-8
31
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3,Phase 1 1197-18-8 5526
32
Tranylcypromine Approved Phase 4 155-09-9 441233
33
Nabumetone Approved Phase 4 42924-53-8 4409
34
Ropivacaine Approved Phase 4,Phase 2,Phase 3 84057-95-4 71273 175805
35
Denosumab Approved Phase 4,Phase 2,Phase 1 615258-40-7
36
Hyoscyamine Approved Phase 4 101-31-5 64692
37
Milnacipran Approved Phase 4 92623-85-3 65833
38
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-41-2 439260
39
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-78-2 2244
40
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 104987-11-3 445643 439492
41
chloroquine Approved, Vet_approved Phase 4,Phase 3,Phase 2 54-05-7 2719
42
Ibuprofen Approved Phase 4,Phase 3,Phase 2 15687-27-1 3672
43
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 79217-60-0, 59865-13-3 5284373 6435893
44
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 22916-47-8 4189
45
Meloxicam Approved, Vet_approved Phase 4,Phase 3,Phase 2 71125-38-7 5281106 54677470
46
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2216-51-5 16666
47
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 57-27-2 5288826
48
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2180-92-9, 38396-39-3 2474
49
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
50
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 124-94-7 31307

Interventional clinical trials:

(show top 50) (show all 5000)
id Name Status NCT ID Phase
1 Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis Unknown status NCT00573651 Phase 4
2 Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis Unknown status NCT00291915 Phase 4
3 Hanyang University Medical Center Arthritis Network Unknown status NCT00418405 Phase 4
4 Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar® Unknown status NCT00828997 Phase 4
5 Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis Unknown status NCT01000441 Phase 4
6 Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis Unknown status NCT02087696 Phase 4
7 Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis Unknown status NCT01939132 Phase 4
8 Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI Unknown status NCT01893151 Phase 4
9 Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis Unknown status NCT01301703 Phase 4
10 The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis Unknown status NCT00808496 Phase 4
11 Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) Unknown status NCT01303874 Phase 4
12 Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis Unknown status NCT01287715 Phase 4
13 TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis Unknown status NCT00908089 Phase 4
14 Remission Induction in Very Early Rheumatoid Arthritis Unknown status NCT00523692 Phase 4
15 Targeting Synovitis in Early Rheumatoid Arthritis Unknown status NCT00920478 Phase 4
16 Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis Unknown status NCT02275299 Phase 4
17 Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis Unknown status NCT01002716 Phase 4
18 Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis Unknown status NCT02024334 Phase 4
19 REstore Working Ability in RheumatoiD Arthritis Unknown status NCT01405326 Phase 4
20 Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) Unknown status NCT01067430 Phase 4
21 Rheumatoid Arthritis Patients in Training Unknown status NCT00434200 Phase 4
22 Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker Unknown status NCT01072058 Phase 4
23 Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes Unknown status NCT02236481 Phase 4
24 Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. Unknown status NCT01835613 Phase 4
25 Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis Unknown status NCT00216177 Phase 4
26 Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Unknown status NCT02132234 Phase 4
27 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Unknown status NCT01282528 Phase 4
28 Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine Unknown status NCT01980836 Phase 4
29 Bucillamine Study of Holding Remission After Infliximab Dose-off Unknown status NCT00716248 Phase 4
30 Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate Unknown status NCT01270035 Phase 4
31 Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis Unknown status NCT00180206 Phase 4
32 Gait Analysis of Ankle Arthroplasty and Arthrodesis Unknown status NCT00921076 Phase 4
33 Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis Unknown status NCT01223976 Phase 4
34 Bone Forming at Prosthetic Surfaces. Fingerprint2 Unknown status NCT01623687 Phase 4
35 Corticosteroids as Additive in Temporomandibular Joint (TMJ) Arthrocentesis Unknown status NCT01275014 Phase 4
36 The Long-term Evaluation of Glucosamine Sulphate Study Unknown status NCT00513422 Phase 4
37 Investigation of Sacroiliac Fusion Treatment (INSITE) Unknown status NCT01681004 Phase 4
38 The Effect of Spironolactone on Pain in Older People With Osteoarthritis Unknown status NCT02046668 Phase 4
39 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
40 Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Unknown status NCT00815282 Phase 4
41 A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis Unknown status NCT01985165 Phase 4
42 Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis Unknown status NCT02484508 Phase 4
43 Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis Unknown status NCT02355236 Phase 4
44 Validation of a Stress Device for the Knee Unknown status NCT02444663 Phase 4
45 The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator Unknown status NCT00422643 Phase 4
46 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Unknown status NCT01088165 Phase 4
47 An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst Unknown status NCT02154789 Phase 4
48 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4
49 Close Kinect Chain Exercise With Kinesio Taping in the Management of Patellofemoral Pain Syndrome Unknown status NCT02241148 Phase 4
50 Bipolar Sealer Aquamantys Use in Total Knee Replacement Unknown status NCT01736644 Phase 4

Search NIH Clinical Center for Arthritis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Arthritis cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Arthritis:
AlloStem
Embryonic/Adult Cultured Cells Related to Arthritis:
Adipose-derived mesenchymal stem cells combined with allograft bone (AlloStem PMIDs: 22500696

Cochrane evidence based reviews: arthritis

Genetic Tests for Arthritis

Genetic tests related to Arthritis:

id Genetic test Affiliating Genes
1 Arthritis 29

Anatomical Context for Arthritis

MalaCards organs/tissues related to Arthritis:

39
T Cells, Bone, Monocytes, Endothelial, B Cells, Neutrophil, Skin

The Foundational Model of Anatomy Ontology organs/tissues related to Arthritis:

18
Joint, Skin Over The Joint

Publications for Arthritis

Articles related to Arthritis:

(show top 50) (show all 12948)
id Title Authors Year
1
The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study. ( 28086960 )
2017
2
Early recognition and detection of juvenile psoriatic arthritis: a call for a standardized approach to screening. ( 28044348 )
2017
3
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration. ( 28089978 )
2017
4
The functional variants of endothelial nitric oxide synthase gene associated with rheumatoid arthritis in Turkish adults. ( 27695991 )
2017
5
Umbilical Plaque in Psoriatic Arthritis. ( 28090061 )
2017
6
CD147 modulates the differentiation of T-helper 17 cells in patients with rheumatoid arthritis. ( 27859685 )
2017
7
Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis. ( 28088452 )
2017
8
Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients. ( 28496328 )
2017
9
Musculoskeletal ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review. ( 28521047 )
2017
10
Lichen amyloidosis associated with rheumatoid arthritis: unique presentation in a Bulgarian patient. ( 28076615 )
2017
11
Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity? ( 28488125 )
2017
12
Tumor necrosis factor inhibitors in psoriatic arthritis. ( 28490202 )
2017
13
Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis. ( 28507445 )
2017
14
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. ( 28087506 )
2017
15
Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study. ( 28089968 )
2017
16
CCR5I932 and the genetic susceptibility to rheumatoid arthritis in admixed populations: a multicentre study. ( 28082621 )
2017
17
Ankylosis of the Temporomandibular Joint and Reconstruction With a Costochondral Graft in a Patient With Juvenile Idiopathic Arthritis. ( 27930467 )
2017
18
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. ( 28529116 )
2017
19
Epidemiology: Time to revisit the concept of reactive arthritis. ( 28490789 )
2017
20
Factors associated with hand joint destruction in Chinese patients with rheumatoid arthritis. ( 28532395 )
2017
21
Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics. ( 28493493 )
2017
22
Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report. ( 28487504 )
2017
23
Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. ( 28483767 )
2017
24
Disease Characteristics and Rheumatoid Arthritis Development in Patients with Early Undifferentiated Arthritis: A 2-year Followup Study. ( 28089976 )
2017
25
Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project. ( 28042124 )
2017
26
Focal segmental glomerulosclerosis lagged behind the onset of rheumatoid arthritis by 7 years: A case report and literature review. ( 28072731 )
2017
27
Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis. ( 28507491 )
2017
28
Ex vivo all-trans retinoic acid modulates NO production and regulates IL-6 effect during rheumatoid arthritis: a study in Algerian patients. ( 28211306 )
2017
29
Effectiveness of conventional disease-modifying antirheumatic drugs in psoriatic arthritis: A systematic review. ( 28089501 )
2017
30
TNFR1 and TNFR2 differentially mediate TNF-I+-induced inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes. ( 28150360 )
2017
31
Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study. ( 28089982 )
2017
32
Association between circulating transforming growth factor-I^1 level and polymorphisms in systemic lupus erythematosus and rheumatoid arthritis: A meta-analysis. ( 28234629 )
2017
33
Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis. ( 28079502 )
2017
34
Pregnancy Outcomes in Patients with Psoriatic Arthritis. ( 28042130 )
2017
35
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine. ( 28081972 )
2017
36
The coexistence of SAPHO syndrome and rheumatoid arthritis: A case report. ( 28072711 )
2017
37
Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies. ( 28154345 )
2017
38
Genetic association of aromatic hydrocarbon receptor and its repressor gene polymorphisms with risk of rheumatoid arthritis in Han Chinese populations. ( 28403070 )
2017
39
Interleukin 12B gene polymorphisms and susceptibility to rheumatoid arthritis: a data synthesis. ( 27312970 )
2017
40
IL-17 and IFN-I^ producing NK and I^I'-T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis. ( 28390966 )
2017
41
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. ( 28081709 )
2017
42
Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis. ( 28083614 )
2017
43
Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease? ( 28086844 )
2017
44
Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies. ( 28089967 )
2017
45
Tear Fluid Protein Changes in Dry Eye Syndrome Associated with Rheumatoid Arthritis: A Proteomic Approach. ( 27789276 )
2017
46
Prevalence of Chlamydia-associated reactive arthritis. ( 28067600 )
2017
47
Need for improvements in reported cost effectiveness ofA adalimumab in rheumatoid arthritis. ( 28084542 )
2017
48
Healthcare burden of depression in adults with arthritis. ( 28092207 )
2017
49
Abnormal Glucose Metabolism in Rheumatoid Arthritis. ( 28529957 )
2017
50
A Retrospective Analysis of Subaxial Subluxation After Atlanto-axial Arthrodesis in Patients With Rheumatoid Arthritis Based on Annual Radiographs Obtained for 5 Years. ( 28525484 )
2017